Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,089 | 464 | 77.6% |
| Consulting Fee | $2,160 | 1 | 18.4% |
| Education | $471.14 | 10 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $3,240 | 67 | $0 (2024) |
| Amgen Inc. | $1,534 | 81 | $0 (2024) |
| ABBVIE INC. | $1,488 | 81 | $0 (2024) |
| UCB, Inc. | $995.89 | 43 | $0 (2024) |
| Genentech USA, Inc. | $657.93 | 31 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $587.77 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $419.99 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $383.50 | 22 | $0 (2024) |
| Radius Health, Inc. | $336.06 | 16 | $0 (2024) |
| PFIZER INC. | $273.50 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,596 | 149 | Janssen Biotech, Inc. ($2,430) |
| 2023 | $2,254 | 121 | UCB, Inc. ($432.22) |
| 2022 | $891.89 | 55 | Janssen Biotech, Inc. ($258.62) |
| 2021 | $498.03 | 38 | Janssen Biotech, Inc. ($151.84) |
| 2020 | $109.54 | 7 | E.R. Squibb & Sons, L.L.C. ($66.94) |
| 2019 | $659.90 | 23 | Amgen Inc. ($153.60) |
| 2018 | $1,033 | 55 | Genentech USA, Inc. ($379.73) |
| 2017 | $677.96 | 27 | Amgen Inc. ($294.26) |
All Payment Transactions
475 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: Bone Health | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Fresenius Kabi USA, LLC | Tyenne (Biological) | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: Biosimilars | ||||||
| 11/26/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $29.06 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/06/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: Immunology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: Not Applicable | ||||||
| 10/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $118.78 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 627 | 51,208 | $1.7M | $345,127 |
| 2022 | 10 | 517 | 36,210 | $1.2M | $271,641 |
| 2021 | 7 | 364 | 863 | $229,590 | $65,993 |
| 2020 | 6 | 282 | 608 | $184,910 | $48,441 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2023 | 15 | 49,200 | $1.1M | $192,996 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 602 | $250,500 | $68,749 | 27.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 42 | 436 | $152,600 | $32,643 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 118 | 118 | $64,500 | $17,434 | 27.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 13 | 97 | $97,000 | $13,118 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 119 | $39,050 | $9,619 | 24.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 38 | 69 | $34,500 | $6,486 | 18.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 205 | $7,240 | $3,384 | 46.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 23 | $2,300 | $295.05 | 12.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 42 | 314 | $3,140 | $264.74 | 8.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 18 | 25 | $500.00 | $139.80 | 28.0% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 11 | 32,000 | $704,000 | $143,225 | 20.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 380 | $133,000 | $43,445 | 32.7% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2022 | 20 | 2,675 | $143,100 | $34,121 | 23.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 94 | 94 | $42,300 | $13,771 | 32.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 40 | 117 | $58,500 | $13,086 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 120 | $36,000 | $9,328 | 25.9% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 18 | 113 | $39,550 | $9,216 | 23.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 17 | 196 | $7,200 | $3,031 | 42.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 35 | 152 | $15,200 | $2,090 | 13.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 43 | 363 | $3,630 | $327.50 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 139 | 324 | $113,400 | $36,891 | 32.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 65 | 137 | $41,100 | $11,371 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 69 | 69 | $31,050 | $10,006 | 32.2% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 25 | 55 | $28,000 | $5,524 | 19.7% |
About Dr. Khurram Abbass, MD
Dr. Khurram Abbass, MD is a Internal Medicine healthcare provider based in San Jose, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154455178.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khurram Abbass, MD has received a total of $11,720 in payments from pharmaceutical and medical device companies, with $5,596 received in 2024. These payments were reported across 475 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($9,089).
As a Medicare-enrolled provider, Abbass has provided services to 1,790 Medicare beneficiaries, totaling 88,889 services with total Medicare billing of $731,203. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Rheumatology
- Location San Jose, CA
- Active Since 03/14/2007
- Last Updated 08/17/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154455178
Products in Payments
- TREMFYA (Drug) $3,007
- RINVOQ (Biological) $1,159
- Cimzia (Drug) $879.37
- Enbrel (Biological) $804.65
- SAPHNELO (Biological) $587.77
- Actemra (Biological) $409.65
- ORENCIA (Biological) $396.92
- BENLYSTA (Biological) $383.50
- EVENITY (Biological) $317.92
- Tymlos (Drug) $281.57
- XELJANZ (Drug) $273.50
- Rituxan (Biological) $248.28
- STELARA (Biological) $237.00
- Arcalyst (Drug) $187.70
- SKYRIZI (Biological) $178.71
- IDACIO (Biological) $168.17
- ACTHAR (Biological) $150.31
- Prolia (Biological) $145.99
- Bimzelx (Biological) $116.52
- TALTZ (Drug) $111.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Jose
Anjali Saxena, Md, MD
Internal Medicine — Payments: $185,928
Richard Kramer, Md, MD
Internal Medicine — Payments: $98,619
Dr. Bhargava Gannavarapu, M.d, M.D
Internal Medicine — Payments: $44,860
Dr. Jose Maria Guanzon, Md, MD
Internal Medicine — Payments: $39,804
Dr. Teresita Guanzon, Md, MD
Internal Medicine — Payments: $35,221
Joann Nguyen, M.d, M.D
Internal Medicine — Payments: $35,164